The primary goal of HPV vaccination is to reduce the incidence of HPV-related diseases, particularly cervical cancer. By preventing the initial infection with high-risk HPV types, vaccines can significantly decrease the prevalence of these cancers. Epidemiological studies have demonstrated a marked reduction in the rates of cervical dysplasia and genital warts in populations with high vaccination coverage.
